SS-31 and NMN: Two paths to improve metabolism and function in aged hearts

Plain-language summary

Published 2020 in Aging Cell, this work by Whitson JA and collaborators tackles a specific question within benefits-focused NMN/NAD+ research.

Key findings reported by the authors

• Mechanistic study in Aging Cell (2020) on NAD+/sirtuin/longevity biology
• Adds to the foundational literature underlying NMN supplementation rationale
• First author: Whitson JA

What this means for Malaysian buyers

For readers in Malaysia weighing whether to start or continue NMN supplementation, this paper sits at the limited end of the evidence spectrum. Limited-tier evidence (mouse, in-vitro, or single small pilot) is hypothesis-generating only; do not extrapolate dosing or efficacy claims to humans without supporting replication. Findings here are most directly relevant to benefits decisions, with secondary relevance to science. Our editorial methodology weights human placebo-controlled trials above mouse mechanistic work above review articles.